In clinical trials, diarrhea was reported by approximately 20 to 30% of participants taking semaglutide or tirzepatide
Nausea and vomiting: Nausea is the most frequently reported side effect, affecting up to 50% of patients taking GLP-1 drugs
180,181,183 GLP-1 also activates the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, which is crucial for maintaining the survival and function of pancreatic -cells
At the same time insulin releasing function of GLP-1 has to be maintained
Even modest weight loss (510% of body weight) can improve metabolic hormone dynamics
Antes de cualquier operacin, revisa si tu mtodo preferido admite retiros parciales, si hay lmites diarios o mensuales, y si existen procesos de autenticacin de dos factores que refuercen la seguridad de tu cuenta